➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
Dow
AstraZeneca
Boehringer Ingelheim
Harvard Business School

Last Updated: July 10, 2020

DrugPatentWatch Database Preview

Patent Applications for MYLERAN


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

US Patent Applications for MYLERAN

US Patent Application Patent No. Title Patent Filing Date Patent Application Status Status Updated
  Start Trial   Start Trial CELL DELIVERY COMPOSITIONS 1999-02-17 Patented Case 2004-01-29
  Start Trial   Start Trial 5-ANDROSTENE-3B,17XDIOL AS AN INHIBITOR OF TUMOR GROWTH 1999-01-06 Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 2010-01-18
  Start Trial   Start Trial NEW TAXOIDS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM 2001-01-16 Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 2006-06-12
  Start Trial   Start Trial PHARMACEUTICAL COMPOSITION FOR AND METHOD OF TREATING LEUKEMIA 2001-02-23 Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 2011-05-23
  Start Trial   Start Trial Antisense modulation of focal adhesion kinase expression 2001-01-09 Abandoned -- Failure to Respond to an Office Action 2004-04-14
  Start Trial   Start Trial 26934, A NOVEL CYTIDINE DEAMINASE-LIKE MOLECULE AND USES THEREOF 2001-03-09 Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 2008-05-19
  Start Trial   Start Trial Methods and products for tumor immunotherapy 2000-12-27 Abandoned -- Failure to Respond to an Office Action 2003-10-28
>US Patent Application >Patent No. >Title >Patent Filing Date >Patent Application Status >Status Updated

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Boehringer Ingelheim
Baxter
Moodys
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.